A vision test using a 2.5%-contrast letter chart is more effective than the conventional 100%-contrast chart at detecting previous episodes…
Articles by Marta Figueiredo, PhD
Aeterna Zentaris GmbH has acquired exclusive global rights to develop, manufacture, and commercialize highly-specific, autoimmune modifying proteins for the treatment…
CorEvitas and the Guthy-Jackson Charitable Foundation (GJCF) announced plans to launch a registry study for people with…
The first three months after giving birth are a particularly high-risk time for developing neuromyelitis optica spectrum disorder (NMOSD)…
Long-term treatment with Uplizna (inebilizumab-cdon) is safe and sustainably reduces the frequency of attacks in adults with neuromyelitis optica…
People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of…
Experiencing disease relapses after receiving a placebo in a clinical trial may change the perception of health in participants with…